drugset / Trial / NCT00449202

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

NCT00449202 ↗

Phase 2 Unknown 100 enrolled Manhattan Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety, preliminary efficacy, and pharmacokinetics of two 14-day cycles of escalating oral doses of MP 101 in 100 obese adult subjects.

Timeline

Start
2006-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject oleoyl-estrone Unknown — Oral

Indications